FindTrial
Sign In

A randomised, double blind, multicentre Italian study, to assess the efficacy and tolerability of octatropine methilbromide in combination with diazepam(Valpinax) compared versus placebo in the treatment of IBS.

A randomised, double blind, multicentre Italian study, to assess the efficacy and tolerability of octatropine methilbromide in combination with diazepam(Valpinax) compared versus placebo in the treatment of IBS.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-000980-93-IT
Enrollment
Unknown
Registered
2005-06-28
Start date
2005-05-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vascular disease at thrombotic risk MedDRA version: 6.1 Level: PT Classification code 10023003

Interventions

Product Name: NA Product Code: NA Pharmaceutical Form: Tablet INN or Proposed INN: VARI Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 40-

Sponsors

CRINOS S.P.A.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026